Feb 3 | Video
A new drug may help fight skin cancer in areas of the skin where traditional treatments don't always work.
|
Jan 26 | News
Surprising results from two new studies may reopen debate about the value of Avastin for breast cancer. The drug helped make tumors disappear in certain women with early-stage disease, researchers found.
|
Jan 17 | News
Constellation Pharmaceuticals, Inc., today announced that it has entered into a major strategic agreement with Genentech, a member of the Roche Group, to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop innovative treatments for cancer and other serious diseases.
|
Jan 9 | News
Xenon today announced a strategic alliance with Genentech, a member of the Roche Group, to discover and develop compounds and companion diagnostics for the potential treatment of pain.
|
Jan 5 | Video
Two recent studies show that Avastin, already approved for other cancers - but still controversial, could help women buy more time in their fight against ovarian cancer.
|
Jan 3 | News
Regeneron Pharmaceuticals, Inc. today announced that the company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEAT (aflibercept) Injection.
|
Nov 21 2011 | News
WASHINGTON (AP) — The government delivered a blow to some desperate patients Friday as it ruled the blockbuster drug Avastin should no longer be used to treat advanced breast cancer.
|
Sep 12 2011 | News
Genentech, a member of the Roche Group, today announced that the company has submitted a New Drug Application for vismodegib to the FDA for the treatment of people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.
|
Jul 13 2011 | News
When flu season arrives this fall, a liquid form of Tamiflu—the most widely used anti-viral flu medication—will be available in a new, lower concentration to reduce the possibility of medication errors.
|
Jul 11 2011 | News
PDL BioPharma, Inc. has announced
that on July 7, 2011, the Second Judicial District Court of Nevada ruled in
favor of PDL on two motions to dismiss filed by Genentech and F. Hoffmann
LaRoche, Ltd. (Roche) in PDL's lawsuit related to the 2003 settlement agreement
with Genentech.
|